{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:58:02Z","timestamp":1781089082445,"version":"3.54.1"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["NO.2023ZD0505600"],"award-info":[{"award-number":["NO.2023ZD0505600"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"abstract":"<jats:p>\n                    Trigeminal neuralgia (TN) is a debilitating neuropathic pain disorder with profound impacts on quality of life. Although alterations in circulating inflammatory proteins have been reported, observational findings remain inconsistent and are vulnerable to confounding and reverse causation. Whether these immune changes are causal or merely downstream consequences of TN remains uncertain, underscoring the need for robust causal inference methods. We conducted a bidirectional 2-sample Mendelian randomization (MR) analysis to investigate the causal relationships between circulating inflammatory proteins and TN. Genetic instruments for 91 proteins and TN were obtained from large-scale publicly available genome-wide association studies. Five complementary MR estimators were applied \u2013 inverse-variance weighting (IVW), MR-Egger, weighted median, weighted mode, and simple mode \u2013 and sensitivity analyses were performed to evaluate heterogeneity, pleiotropy, and robustness. Forward MR identified 5 proteins significantly associated with TN risk: eotaxin (IVW odds ratio [OR]\u2005=\u20050.834, 95% CI\u2005=\u20050.711\u20130.977,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.025); C-X-C motif chemokine ligand 5 [CXCL5]; IVW OR\u2005=\u20050.841, 95% CI\u2005=\u20050.726\u20130.974,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.021); IL-20RA (IVW OR\u2005=\u20051.317, 95% CI\u2005=\u20051.032\u20131.679,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.027); interleukin-6 (IVW OR\u2005=\u20051.343, 95% CI\u2005=\u20051.059\u20131.704,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.015); and neurturin (IVW OR\u2005=\u20051.190, 95% CI\u2005=\u20051.004\u20131.410,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.044). Reverse MR indicated that TN causally influenced 5 immune traits: eotaxin (OR\u2005=\u20050.39, 95% CI\u2005=\u20050.19\u20130.80,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.010); CXCL5 (OR\u2005=\u20050.32, 95% CI\u2005=\u20050.11\u20130.91,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.032); IL-20RA (OR\u2005=\u20052.07, 95% CI\u2005=\u20051.11\u20133.84,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.022); interleukin-15 receptor \u03b1 (OR\u2005=\u20050.28, 95% CI\u2005=\u20050.08\u20130.99,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.048); and transforming growth factor-\u03b1 (OR\u2005=\u20050.44, 95% CI\u2005=\u20050.23\u20130.83,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.011). Notably, eotaxin, CXCL5, and IL-20RA showed bidirectional associations with TN. All signals were consistent across complementary estimators and sensitivity analyses, with no evidence of heterogeneity or horizontal pleiotropy (all\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05). Our genetic evidence demonstrates a close coupling between the circulating inflammatory network and TN, providing testable leads for biomarker development and immunomodulatory strategies in TN.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047243","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:00:20Z","timestamp":1769191220000},"page":"e47243","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Causal interplay between trigeminal neuralgia and systemic inflammatory markers: A bidirectional Mendelian randomization study"],"prefix":"10.1097","volume":"105","author":[{"given":"Lingsen","family":"Hou","sequence":"first","affiliation":[{"name":"Department of Rehabilitation Medicine, Zhengzhou Anorectal Hospital, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingbo","family":"Hou","sequence":"additional","affiliation":[{"name":"Academy of Zhongjing, Henan University of Chinese Medicine, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Guo","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou University of Chinese Medicine, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8810-7766","authenticated-orcid":false,"given":"Jinzhou","family":"Guo","sequence":"additional","affiliation":[{"name":"Academy of Zhongjing, Henan University of Chinese Medicine, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Cui","sequence":"additional","affiliation":[{"name":"Academy of Zhongjing, Henan University of Chinese Medicine, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260610","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41572-024-00523-z","article-title":"Trigeminal neuralgia.","volume":"10","author":"Ashina","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"R3-20260610","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1177\/0333102416687280","article-title":"Trigeminal neuralgia - diagnosis and treatment.","volume":"37","author":"Maarbjerg","year":"2017","journal-title":"Cephalalgia"},{"key":"R4-20260610","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ca.22157","article-title":"The anatomy of vascular compression in trigeminal neuralgia.","volume":"27","author":"Thomas","year":"2014","journal-title":"Clin Anat"},{"key":"R5-20260610","doi-asserted-by":"crossref","first-page":"1744806920963809","DOI":"10.1177\/1744806920963809","article-title":"Schwann cells and trigeminal neuralgia.","volume":"16","author":"Liao","year":"2020","journal-title":"Mol Pain"},{"key":"R6-20260610","doi-asserted-by":"crossref","first-page":"788578","DOI":"10.3389\/fimmu.2021.788578","article-title":"Editorial: cytokines and pain.","volume":"12","author":"Pinto","year":"2021","journal-title":"Front Immunol"},{"key":"R7-20260610","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1570159X17666191010094350","article-title":"Trigeminal neuralgia: basic and clinical aspects.","volume":"18","author":"Araya","year":"2020","journal-title":"Curr Neuropharmacol"},{"key":"R8-20260610","doi-asserted-by":"crossref","first-page":"7878","DOI":"10.1523\/JNEUROSCI.6053-09.2010","article-title":"Ionic mechanisms underlying inflammatory mediator-induced sensitization of dural afferents.","volume":"30","author":"Vaughn","year":"2010","journal-title":"J Neurosci"},{"key":"R9-20260610","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/01616412.2018.1564188","article-title":"A correlative analysis between inflammatory cytokines and trigeminal neuralgia or hemifacial spasm.","volume":"41","author":"Liu","year":"2019","journal-title":"Neurol Res"},{"key":"R11-20260610","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s10194-025-02026-y","article-title":"Association between mental disorders and trigeminal neuralgia: a cohort study and Mendelian randomization analysis.","volume":"26","author":"Wang","year":"2025","journal-title":"J Headache Pain"},{"key":"R12-20260610","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.csbj.2022.05.015","article-title":"Statistical methods for Mendelian randomization in genome-wide association studies: a review.","volume":"20","author":"Boehm","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"R13-20260610","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1177\/0962280215597579","article-title":"A review of instrumental variable estimators for Mendelian randomization.","volume":"26","author":"Burgess","year":"2017","journal-title":"Stat Methods Med Res"},{"key":"R14-20260610","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2337\/dc22-1385","article-title":"Gastrointestinal consequences of type 2 diabetes mellitus and impaired glycemic homeostasis: a mendelian randomization study.","volume":"46","author":"Chen","year":"2023","journal-title":"Diabetes Care"},{"key":"R15-20260610","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"},{"key":"R16-20260610","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy.","volume":"52","author":"Orr\u00f9","year":"2020","journal-title":"Nat Genet"},{"key":"R17-20260610","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation.","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"R18-20260610","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/add.15767","article-title":"Genetic liability for prescription opioid use and risk of cardiovascular diseases: a multivariable Mendelian randomization study.","volume":"117","author":"Cai","year":"2022","journal-title":"Addiction (Abingdon, England)"},{"key":"R19-20260610","doi-asserted-by":"crossref","first-page":"1333855","DOI":"10.3389\/fgene.2024.1333855","article-title":"A mendelian randomization study investigates the causal relationship between immune cell phenotypes and cerebral aneurysm.","volume":"15","author":"Shi","year":"2024","journal-title":"Front Genet"},{"key":"R20-20260610","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption.","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R21-20260610","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R22-20260610","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R23-20260610","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/ije\/dyq151","article-title":"Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants.","volume":"40","author":"Pierce","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R24-20260610","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-egger method.","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R25-20260610","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R26-20260610","doi-asserted-by":"crossref","first-page":"781310","DOI":"10.3389\/fimmu.2021.781310","article-title":"Blockade of CC chemokine receptor type 3 diminishes pain and enhances opioid analgesic potency in a model of neuropathic pain.","volume":"12","author":"Pawlik","year":"2021","journal-title":"Front Immunol"},{"key":"R27-20260610","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41232-025-00375-4","article-title":"The dual roles of chemokines in peripheral nerve injury and repair.","volume":"45","author":"Wang","year":"2025","journal-title":"Inflammation and regeneration"},{"key":"R28-20260610","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s13760-022-01984-3","article-title":"Eotaxin-1 (CCL11) in neuroinflammatory disorders and possible role in COVID-19 neurologic complications.","volume":"122","author":"Nazarinia","year":"2022","journal-title":"Acta Neurol Belg"},{"key":"R29-20260610","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1097\/j.pain.0000000000001061","article-title":"High levels of cerebrospinal fluid chemokines point to the presence of neuroinflammation in peripheral neuropathic pain: a cross-sectional study of 2 cohorts of patients compared with healthy controls.","volume":"158","author":"B\u00e4ckryd","year":"2017","journal-title":"Pain"},{"key":"R30-20260610","doi-asserted-by":"crossref","first-page":"e1135","DOI":"10.1097\/PR9.0000000000001135","article-title":"The role of cytokines and chemokines in the maintenance of chronic pain-a pilot study.","volume":"9","author":"Lassen","year":"2024","journal-title":"Pain reports"},{"key":"R31-20260610","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ibneur.2024.08.002","article-title":"Chemokines play a role in nerve damage and neuroprotection in vascular dementia.","volume":"17","author":"Ma","year":"2024","journal-title":"IBRO Neurosci Rep"},{"key":"R32-20260610","doi-asserted-by":"crossref","first-page":"90ra60","DOI":"10.1126\/scitranslmed.3002193","article-title":"CXCL5 mediates UVB irradiation-induced pain.","volume":"3","author":"Dawes","year":"2011","journal-title":"Sci Transl Med"},{"key":"R33-20260610","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12883-016-0622-3","article-title":"Increased plasma levels of epithelial neutrophil-activating peptide 78\/CXCL5 during the remission of Neuromyelitis optica.","volume":"16","author":"Yang","year":"2016","journal-title":"BMC Neurol"},{"key":"R34-20260610","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1038\/s41467-024-47640-7","article-title":"CXCL5 activates CXCR2 in nociceptive sensory neurons to drive joint pain and inflammation in experimental gouty arthritis.","volume":"15","author":"Yin","year":"2024","journal-title":"Nat Commun"},{"key":"R35-20260610","doi-asserted-by":"crossref","first-page":"e1117","DOI":"10.1097\/PR9.0000000000001117","article-title":"Heightened presence of inflammatory mediators in the cerebrospinal fluid of patients with trigeminal neuralgia.","volume":"8","author":"Ostertag","year":"2023","journal-title":"Pain reports"},{"key":"R36-20260610","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.3390\/molecules28155766","article-title":"Targeting members of the chemokine family as a novel approach to treating neuropathic pain.","volume":"28","author":"Pawlik","year":"2023","journal-title":"Molecules (Basel, Switzerland)"},{"key":"R37-20260610","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1743-6109.2010.02128.x","article-title":"Adipose tissue-derived stem cells secrete CXCL5 cytokine with neurotrophic effects on cavernous nerve regeneration.","volume":"8","author":"Zhang","year":"2011","journal-title":"J Sex Med"},{"key":"R38-20260610","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3390\/ijms23020627","article-title":"Interleukin-24 immunobiology and its roles in inflammatory diseases.","volume":"23","author":"Zhong","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R39-20260610","doi-asserted-by":"crossref","first-page":"114399","DOI":"10.1016\/j.intimp.2025.114399","article-title":"Unraveling the role of the IL-20 cytokine family in neurodegenerative diseases: mechanisms and therapeutic insights.","volume":"152","author":"Goleij","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"R40-20260610","doi-asserted-by":"crossref","first-page":"114643","DOI":"10.1016\/j.expneurol.2023.114643","article-title":"Spinal interleukin-24 contributes to neuropathic pain after peripheral nerve injury through interleukin-20 receptor2 in mice.","volume":"372","author":"Cai","year":"2024","journal-title":"Exp Neurol"},{"key":"R42-20260610","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/procel\/pwae030","article-title":"IL-24 promotes atopic dermatitis-like inflammation through driving MRSA-induced allergic responses.","volume":"16","author":"Qian","year":"2025","journal-title":"Protein & cell"},{"key":"R43-20260610","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/j.pain.0000000000001831","article-title":"Targeting interleukin-20 alleviates paclitaxel-induced peripheral neuropathy.","volume":"161","author":"Chen","year":"2020","journal-title":"Pain"},{"key":"R44-20260610","doi-asserted-by":"crossref","first-page":"689314","DOI":"10.3389\/fpain.2021.689314","article-title":"Chemokines and pain in the trigeminal system.","volume":"2","author":"Solis-Castro","year":"2021","journal-title":"Front Pain Res (Lausanne)"},{"key":"R45-20260610","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12974-016-0607-6","article-title":"Interleukin-6: an emerging regulator of pathological pain.","volume":"13","author":"Zhou","year":"2016","journal-title":"J Neuroinflammation"},{"key":"R46-20260610","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.expneurol.2014.04.006","article-title":"Cytokine pathways regulating glial and leukocyte function after spinal cord and peripheral nerve injury.","volume":"258","author":"Bastien","year":"2014","journal-title":"Exp Neurol"},{"key":"R47-20260610","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12974-024-03049-z","article-title":"IL-6 from cerebrospinal fluid causes widespread pain via STAT3-mediated astrocytosis in chronic constriction injury of the infraorbital nerve.","volume":"21","author":"Yu","year":"2024","journal-title":"J Neuroinflammation"},{"key":"R48-20260610","doi-asserted-by":"crossref","first-page":"13615","DOI":"10.18632\/aging.202887","article-title":"The effect of IL-6\/Piezo2 on the trigeminal neuropathic pain.","volume":"13","author":"Liu","year":"2021","journal-title":"Aging (Milano)"},{"key":"R49-20260610","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.12659\/MSM.896355","article-title":"Interleukin-6 (IL-6) receptor antagonist protects against rheumatoid arthritis.","volume":"22","author":"Li","year":"2016","journal-title":"Med Sci Monit"},{"key":"R50-20260610","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1152\/jn.00731.2016","article-title":"Cutaneous neurturin overexpression alters mechanical, thermal, and cold responsiveness in physiologically identified primary afferents.","volume":"117","author":"Jankowski","year":"2017","journal-title":"J Neurophysiol"},{"key":"R51-20260610","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2147\/JPR.S247472","article-title":"Nerve growth factor signaling and its contribution to pain.","volume":"13","author":"Barker","year":"2020","journal-title":"J Pain Res"},{"key":"R52-20260610","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1523\/JNEUROSCI.0421-18.2018","article-title":"GDNF, neurturin, and artemin activate and sensitize bone afferent neurons and contribute to inflammatory bone pain.","volume":"38","author":"Nencini","year":"2018","journal-title":"J Neurosci"},{"key":"R53-20260610","first-page":"E583","article-title":"Pancreatic cancer related pain: review of pathophysiology and intrathecal drug delivery systems for pain management.","volume":"24","author":"Carvajal","year":"2021","journal-title":"Pain Physician"},{"key":"R54-20260610","doi-asserted-by":"crossref","first-page":"9721","DOI":"10.1073\/pnas.0603286103","article-title":"IL-15 mediates immune inflammatory hypernociception by triggering a sequential release of IFN-gamma, endothelin, and prostaglandin.","volume":"103","author":"Verri","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"R55-20260610","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/glia.20920","article-title":"Blockade of IL-15 activity inhibits microglial activation through the NFkappaB, p38, and ERK1\/2 pathways, reducing cytokine and chemokine release.","volume":"58","author":"Gomez-Nicola","year":"2010","journal-title":"Glia"},{"key":"R56-20260610","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/glia.20628","article-title":"Interleukin 15 expression in the CNS: blockade of its activity prevents glial activation after an inflammatory injury.","volume":"56","author":"G\u00f3mez-Nicola","year":"2008","journal-title":"Glia"},{"key":"R57-20260610","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1111\/j.1471-4159.2008.05746.x","article-title":"Role of IL-15 in spinal cord and sciatic nerve after chronic constriction injury: regulation of macrophage and T-cell infiltration.","volume":"107","author":"G\u00f3mez-Nicola","year":"2008","journal-title":"J Neurochem"},{"key":"R58-20260610","first-page":"1277","article-title":"Astrocyte-microglia crosstalk: a novel target for the treatment of migraine.","volume":"15","author":"Sun","year":"2024","journal-title":"Aging and disease"},{"key":"R60-20260610","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1172\/JCI87406","article-title":"Epiregulin and EGFR interactions are involved in pain processing.","volume":"127","author":"Martin","year":"2017","journal-title":"J Clin Invest"},{"key":"R61-20260610","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12974-019-1524-2","article-title":"An update on reactive astrocytes in chronic pain.","volume":"16","author":"Li","year":"2019","journal-title":"J Neuroinflammation"},{"key":"R62-20260610","doi-asserted-by":"crossref","first-page":"6428","DOI":"10.1523\/JNEUROSCI.1037-07.2007","article-title":"Inhibiting epidermal growth factor receptor improves structural, locomotor, sensory, and bladder recovery from experimental spinal cord injury.","volume":"27","author":"Erschbamer","year":"2007","journal-title":"J Neurosci"},{"key":"R63-20260610","doi-asserted-by":"crossref","first-page":"eadr9397","DOI":"10.1126\/scisignal.adr9397","article-title":"Amphiregulin contributes to neuropathic pain by enhancing glycolysis that stimulates histone lactylation in sensory neurons.","volume":"18","author":"Deng","year":"2025","journal-title":"Sci Signaling"},{"key":"R64-20260610","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.12688\/f1000research.9025.1","article-title":"EGF receptor ligands: recent advances.","volume":"5","author":"Singh","year":"2016","journal-title":"F1000Research"},{"key":"R65-20260610","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3390\/ph16111558","article-title":"Repurposing EGFR inhibitors for oral cancer pain and opioid tolerance.","volume":"16","author":"Santi","year":"2023","journal-title":"Pharmaceuticals"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047243","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:00:46Z","timestamp":1781085646000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047243","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"2025-09-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}